Family

+

−

• No Family data available.

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
ALTERGON S A	6903 LUGANO

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• A61P:THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDI....

• 2008 Application Filing Year
• A61K Class
• 9711 Applications Filed
• 5862 Patents Issued To-Date
• 60.37 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Troiano, Angelo	Caslano, CH	2	0
# of filed Patents : 2 Total Citations : 0
Zoppetti, Giorgio	Milan, IT	43	208
# of filed Patents : 43 Total Citations : 208

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 0 Citation Count
• A61K Class

• 0 % this patent is cited more than
• 14 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
May 17, 2011	US,7943668,B2   US7943668B2	GRANTED PATENT AS SECOND PUBLICATION
September 03, 2009	US,20090221707,A1   US20090221707A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 7943668

Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtained

---

Abstract

---

The present invention relates to a process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, its components including as active principle a salt of diclofenac, 2[(2,6-dichlorophenyl)amino]benzene-acetic acid, with a cyclic organic base chosen from hydroxyethylpyrrolidine or hydroxyethylpiperidine characterized in that said active principle is added to a mixture of one or more of said components, in the form of a solution in water and propylene glycol in a ratio of about 1:1 parts by weight.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• MAFP2022
• MAFP2018
• FPAY2014
• I2011
• STCF2011
• P2009
• AS2008
• F2008
• PD2008

Date	Code	Event	Description
Oct 20, 2022	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY year of fee payment: 12
Oct 25, 2018	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY year of fee payment: 8
Oct 23, 2014	FPAY	FEE PAYMENT	year of fee payment: 4
May 17, 2011	I	Issuance
Apr 27, 2011	STCF	INFORMATION ON STATUS: PATENT GRANT	free format text: PATENTED CASE
Sep 03, 2009	P	Published
Apr 15, 2008	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TROIANO, ANGELO;ZOPPETTI, GIORGIO;REEL/FRAME:022273/0179 Owner name: ALTERGON S.A., SWITZERLAND Effective Date: Apr 15, 2008
Mar 03, 2008	F	Filing
Mar 03, 2008	PD	Priority Date